COOL-LAMPS. II. Characterizing the Size and Star Formation History of a Bright Strongly Lensed Early-type Galaxy at Redshift 1.02

We present COOL J1323+0343, an early-type galaxy at z = 1.0153 ± 0.0006, strongly lensed by a cluster of galaxies at z = 0.353 ± 0.001. This object was originally imaged by DECaLS and noted as a gravitational lens by COOL-LAMPS, a collaboration initiated to find strong-lensing systems in recent public optical imaging data, and confirmed with follow-up data. With ground-based grzH imaging and optical spectroscopy from the Las Campanas Observatory and the Nordic Optical Telescope, we derive a stellar mass, metallicity, and star formation history from stellar-population synthesis modeling. The lens modeling implies a total magnification, summed over the three images in the arc, of μ ∼ 113. The stellar mass in the source plane is M * ∼ 10.64 M ⊙ and the 1σ upper limit on the star formation rate (SFR) in the source plane is SFR ∼ 3.75 × 10−2 M ⊙ yr−1 (log sSFR = −12.1 yr−1) in the youngest two age bins (0-100 Myr), closest to the epoch of observation. Our measurements place COOL J1323+0343 below the characteristic mass of the stellar mass function, making it an especially compelling target that could help clarify how intermediate-mass quiescent galaxies evolve. We reconstruct COOL J1323+0343 in the source plane and fit its light profile. This object is below the expected size evolution of an early-type galaxy at this mass with an effective radius re ∼ 0.5 kpc. This extraordinarily magnified and bright lensed early-type galaxy offers an exciting opportunity to study the morphology and star formation history of an intermediate-mass early-type galaxy in detail at z ∼ 1. © 2022. The Author(s). Published by the American Astronomical Society.Open access journalThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at [email protected]

Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE):an international observational study

Background: Stroke disproportionately affects people in low-income and middle-income countries. Although improvements in stroke care and outcomes have been reported in high-income countries, little is known about practice and outcomes in low and middle-income countries. We aimed to compare patterns of care available and their association with patient outcomes across countries at different economic levels. Methods: We studied the patterns and effect of practice variations (ie, treatments used and access to services) among participants in the INTERSTROKE study, an international observational study that enrolled 13 447 stroke patients from 142 clinical sites in 32 countries between Jan 11, 2007, and Aug 8, 2015. We supplemented patient data with a questionnaire about health-care and stroke service facilities at all participating hospitals. Using univariate and multivariate regression analyses to account for patient casemix and service clustering, we estimated the association between services available, treatments given, and patient outcomes (death or dependency) at 1 month. Findings: We obtained full information for 12 342 (92%) of 13 447 INTERSTROKE patients, from 108 hospitals in 28 countries; 2576 from 38 hospitals in ten high-income countries and 9766 from 70 hospitals in 18 low and middle-income countries. Patients in low-income and middle-income countries more often had severe strokes, intracerebral haemorrhage, poorer access to services, and used fewer investigations and treatments (p<0·0001) than those in high-income countries, although only differences in patient characteristics explained the poorer clinical outcomes in low and middle-income countries. However across all countries, irrespective of economic level, access to a stroke unit was associated with improved use of investigations and treatments, access to other rehabilitation services, and improved survival without severe dependency (odds ratio [OR] 1·29; 95% CI 1·14–1·44; all p<0·0001), which was independent of patient casemix characteristics and other measures of care. Use of acute antiplatelet treatment was associated with improved survival (1·39; 1·12–1·72) irrespective of other patient and service characteristics. Interpretation: Evidence-based treatments, diagnostics, and stroke units were less commonly available or used in low and middle-income countries. Access to stroke units and appropriate use of antiplatelet treatment were associated with improved recovery. Improved care and facilities in low-income and middle-income countries are essential to improve outcomes